Menopausal symptoms: Short-term treatment of signs and symptoms of oestrogen deficiency due to menopause, whether natural or surgically induced. In women with an intact uterus, oestrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals (Refer to CLINICAL TRIALS and DOSAGE AND ADMINISTRATION). Prevention of post-menopausal bone mineral density loss: Estraderm MX 50, 75 and 100 may be used for prevention of post-menopausal bone mineral density loss in women with an increased risk of future osteoporotic fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of bone mineral density loss. When prescribed solely for the prevention of postmenopausal bone mineral density loss, therapy should only be prescribed for women who are at high risk of future fracture and who are intolerant of, or contraindicated for, non-oestrogen products approved for prevention of bone mineral density loss. Lifestyle modifications and the risk-benefit profile of Estraderm MX should be taken into careful consideration and discussed with the patient to allow the patient to make an informed decision prior to prescribing( See PRECAUTIONS and DOSAGE AND ADMINISTRATION). Combination HRT should not be used in hysterectomised women because it is not needed in these women and it may increase risk of breast cancer.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
The way to take this medicine: Transdermal
Store below 25 degrees Celsius
Shelf lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
A translucent, colourless system, about 6.1cm in diameter, square, with rounded corners, on an oversized transparent protective liner. The backing film is imprinted with code "CG HKH".
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Menopausal symptoms: Short-term treatment of signs and symptoms of oestrogen deficiency due to menopause, whether natural or surgically induced. In women with an intact uterus, oestrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals (Refer to CLINICAL TRIALS and DOSAGE AND ADMINISTRATION). Prevention of post-menopausal bone mineral density loss: Estraderm MX 50, 75 and 100 may be used for prevention of post-menopausal bone mineral density loss in women with an increased risk of future osteoporotic fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of bone mineral density loss. When prescribed solely for the prevention of postmenopausal bone mineral density loss, therapy should only be prescribed for women who are at high risk of future fracture and who are intolerant of, or contraindicated for, non-oestrogen products approved for prevention of bone mineral density loss. Lifestyle modifications and the risk-benefit profile of Estraderm MX should be taken into careful consideration and discussed with the patient to allow the patient to make an informed decision prior to prescribing( See PRECAUTIONS and DOSAGE AND ADMINISTRATION). Combination HRT should not be used in hysterectomised women because it is not needed in these women and it may increase risk of breast cancer.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
The way to take this medicine: Transdermal
Store below 25 degrees Celsius
Shelf lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
A translucent, colourless system, about 6.1cm in diameter, square, with rounded corners, on an oversized transparent protective liner. The backing film is imprinted with code "CG HKH".
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Menopausal symptoms: Short-term treatment of signs and symptoms of oestrogen deficiency due to menopause, whether natural or surgically induced. In women with an intact uterus, oestrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals (Refer to CLINICAL TRIALS and DOSAGE AND ADMINISTRATION). Prevention of post-menopausal bone mineral density loss: Estraderm MX 50, 75 and 100 may be used for prevention of post-menopausal bone mineral density loss in women with an increased risk of future osteoporotic fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of bone mineral density loss. When prescribed solely for the prevention of postmenopausal bone mineral density loss, therapy should only be prescribed for women who are at high risk of future fracture and who are intolerant of, or contraindicated for, non-oestrogen products approved for prevention of bone mineral density loss. Lifestyle modifications and the risk-benefit profile of Estraderm MX should be taken into careful consideration and discussed with the patient to allow the patient to make an informed decision prior to prescribing( See PRECAUTIONS and DOSAGE AND ADMINISTRATION). Combination HRT should not be used in hysterectomised women because it is not needed in these women and it may increase risk of breast cancer.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
The way to take this medicine: Transdermal
Store below 25 degrees Celsius
Shelf lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Thin, flat, colourless, translucent multilaminate sheet; 70.11mm in diameter; square with rounded corners and impressed with "CG GTG".
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on February 1, 2019. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Menopausal symptoms: Short-term treatment of signs and symptoms of oestrogen deficiency due to menopause, whether natural or surgically induced. In women with an intact uterus, oestrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals (Refer to CLINICAL TRIALS and DOSAGE AND ADMINISTRATION). Prevention of post-menopausal bone mineral density loss: Estraderm MX 50, 75 and 100 may be used for prevention of post-menopausal bone mineral density loss in women with an increased risk of future osteoporotic fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of bone mineral density loss. When prescribed solely for the prevention of postmenopausal bone mineral density loss, therapy should only be prescribed for women who are at high risk of future fracture and who are intolerant of, or contraindicated for, non-oestrogen products approved for prevention of bone mineral density loss. Lifestyle modifications and the risk-benefit profile of Estraderm MX should be taken into careful consideration and discussed with the patient to allow the patient to make an informed decision prior to prescribing( See PRECAUTIONS and DOSAGE AND ADMINISTRATION). Combination HRT should not be used in hysterectomised women because it is not needed in these women and it may increase risk of breast cancer.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
The way to take this medicine: Transdermal
Store below 25 degrees Celsius
Shelf lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
A translucent, colourless patch, about 4.9cm square with rounded corners, on an oversized, transparent protective liner. The code CG GSG is impressed on the backing side of the patch.
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on February 1, 2019. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Menopausal symptoms: Short-term treatment of signs and symptoms of oestrogen deficiency due to menopause, whether natural or surgically induced. In women with an intact uterus, oestrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals (Refer to CLINICAL TRIALS and DOSAGE AND ADMINISTRATION). Combination HRT should not be used in hysterectomised women because it is not needed in these women and it may increase risk of breast cancer
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
The way to take this medicine: Transdermal
Store below 25 degrees Celsius
Shelf lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
Thin, flat, colourless, translucent multilaminate sheet; 35.13mm in diameter; square with rounded corners and impressed with "CG GRG".
This medicine is available from a pharmacist and requires a prescription. It is
Schedule 4 : Prescription Only Medicine.
Is this medicine subsidised?
This medicine was verified as being available on the PBS (Pharmaceutical Benefits Scheme) on February 1, 2019. To learn more about this subsidy, visit the Pharmaceutical Benefits Scheme (PBS) website.
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
Menopausal symptoms: Short-term treatment of signs and symptoms of oestrogen deficiency due to menopause, whether natural or surgically induced. In women with an intact uterus, oestrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals (Refer to CLINICAL TRIALS and DOSAGE AND ADMINISTRATION). Prevention of post-menopausal bone mineral density loss: Estraderm MX 50, 75 and 100 may be used for prevention of post-menopausal bone mineral density loss in women with an increased risk of future osteoporotic fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of bone mineral density loss. When prescribed solely for the prevention of postmenopausal bone mineral density loss, therapy should only be prescribed for women who are at high risk of future fracture and who are intolerant of, or contraindicated for, non-oestrogen products approved for prevention of bone mineral density loss. Lifestyle modifications and the risk-benefit profile of Estraderm MX should be taken into careful consideration and discussed with the patient to allow the patient to make an informed decision prior to prescribing( See PRECAUTIONS and DOSAGE AND ADMINISTRATION). Combination HRT should not be used in hysterectomised women because it is not needed in these women and it may increase risk of breast cancer.
How to take it
You should seek medical advice in relation to medicines and use only as directed by a healthcare professional.
The way to take this medicine: Transdermal
Store below 25 degrees Celsius
Shelf lifetime is 2 Years.
Always read the label. If symptoms persist see your healthcare professional.
Visual appearance
A translucent, colourless system, about 6.1cm in diameter, square, with rounded corners, on an oversized transparent protective liner. The backing film is imprinted with code "CG HKH".
You should seek advice from your doctor or pharmacist about taking this medicine. They can help you balance the risks and the benefits of this medicine during pregnancy.
